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Oxidants such as superoxide anion, hydrogen peroxide, and myeloperoxidase from activated inﬂammatory cells in the lower
respiratory tract contribute to inﬂammation and injury. Etiologic agents include inorganic particulates such as asbestos, silica,
or coal mine dust or mixtures of inorganic dust and combustion materials found in World Trade Center dust and smoke. These
etiologic agents are phagocytosed by alveolar macrophages or bronchial epithelial cells and release chemotactic factors that recruit
inﬂammatory cells to the lung. Chemotactic factors attract and activate neutrophils, eosinophils, mast cells, and lymphocytes and
further activate macrophages to release more oxidants. Inorganic dusts target alveolar macrophages, World Trade Center dust
targets bronchial epithelial cells, and eosinophils characterize tropical pulmonary eosinophilia (TPE) caused by ﬁlarial organisms.
The technique of bronchoalveolar lavage in humans has recovered alveolar macrophages (AMs) in dust diseases and eosinophils in
TPE that release increased amounts of oxidants in vitro. Interestingly, TPE has massively increased eosinophils in the acute form
and after treatment can still have ongoing eosinophilic inﬂammation. A course of prednisone for one week can reduce the oxidant
burden and attendant inﬂammation and may be a strategy to prevent chronic TPE and interstitial lung disease.
1.Introduction
Gaseous and particulate air pollutants activate inﬂammatory
cells to release oxidants such as superoxide anion, hydrogen
peroxide, and hydroxyl radicals [1]. Oxidants damage pro-
teins, lipids, DNA forming nitrotyrosine, 4-OH-2-nonenal,
and 8-OHdeoxyguanosine, and single strand breaks [2].
Oxidants from macrophages and bronchial epithelial cells
cause inﬂammation leading to injury and ﬁbrosis [3]. These
events are particularly important to the upper airways
leading to asthma and constrictive bronchiolitis and to
the lower respiratory tract where exogenous oxidants can
activate macrophages to release endogenous oxidants, attract
other inﬂammatory cells, and injure the delicate walls of
the peripheral respiratory bronchioles and alveolar sacs [4].
The respiratory tract is a target organ for cigarette smoke,
inorganic dusts (asbestos, silica, and coal), PM2.5,a n d
World Trade Center dust contributing to asthma, COPD,
ﬁbrosis, and constrictive bronchiolitis [5]. Oxidants in the
lung can be from endogenous sources since air pollutants
activate neutrophils, alveolar macrophages, eosinophils, and
epithelial cells. Antioxidants include superoxide dismutase
and glutathione peroxidase.
Oxidants generate airway inﬂammation by activating
NF-κB and derepressing C/EBPβ in macrophages leading to
the production of proinﬂammatory cytokines IL-1β,T N F - α,
IL-8, and IL-6 [6]. Oxidants are a defense mechanism against
pathogens which adds to the amount of oxidative stress.
Cigarettesmoking contributestooxidative stressdirectlyand
stimulates the release of chemokines to attract inﬂammatory
cells [7].
2.InorganicDusts
Occupational exposures to coal, silica, or asbestos are the
major causes of the pneumoconiosis or dust-induced lung2 Mediators of Inﬂammation
diseases [8]. Exposure duration is important with most of
these disorders requiring >10 years and usually >20 years
before these diseases manifest. They continue to progress
despite removal from exposure. Chest radiographs show
small irregular or rounded opacities in increasing profusion,
and profusion correlates with length of exposure. These
opacities may become congruent increasing to 1-2 cen-
timeters or more leading to complicated pneumoconiosis.
Complicated pneumoconiosis or progressive massive ﬁbrosis
frequently leads to respiratory impairment. Symptoms are
mostly shortness of breath with exertion or climbing stairs
although cough, sputum production, and chest pain may
also occur. Intensity of exposure is also important since
workers directly exposed are at greatest risk. These include
coal miners at the face, silica-exposed workers grinding
sand-covered metal or polishing stone, and asbestos workers
applying and cutting insulation or asbestos-formed products
[9]. Pulmonary function tests may show a reduction of
lung volumes consistent with pulmonary ﬁbrosis and/or
airwaysobstructionillustratingdust-relatedairwayirritation
and ﬁbrosis. Smoking is common among this blue-collar
workforce which interacts with dust exposure in causing
respiratory symptoms, changes on the chest X-ray, and,
especially,changesinpulmonaryfunctiontests.Phagocytosis
of particles by alveolar macrophages (AMs) deposited in
the respiratory bronchioles and alveolar ducts and sacs
can activate AM and stimulate the release of oxidants
including superoxide anion and hydrogen peroxide [10,
11]. Measurements of these two in short-term assays of
freshly recovered bronchoalveolar lavage cells have noted
increased levels in patients with coal worker’s pneumoco-
niosis, asbestosis, and silicosis [10, 12]. Levels are increased
in nonsmokers and those who have quit smoking for >5
years, and higher levels are noted in those with respiratory
impairment compared to normal nonsmoking volunteers
[13]. Age does not appear to be a confounder in these assays.
Also, the predominant cell recovered is the AM although
there are signiﬁcant increases in neutrophils and lympho-
cytes consistent with a macrophage alveolitis. Measurements
in 24-hour supernatants from bronchoalveolar lavage cells
usingimmunoassaysshowincreasesinﬁbronectincompared
to nonsmoking controls and increases in peptide growth
factors including platelet-derived growth factor (PDGF),
insulin-like growth factor (IGF-I), and transforming growth
factor-beta (TGF-β)[ 14, 15]. TGF-β has been shown to
be increased using immunohistochemistry of lung biopsies
from workers with chronic or acute silicosis [16]. Cytokines
are also increased in BAL supernatants including IL-6, IL-
8, IL-1β,a n dT N F - α, and Northern analysis has shown the
mechanism to be upregulation of their respective mRNAs
[17, 18]. AMs have a unique transcriptional regulatory
machinery since transcription factors that regulate inﬂam-
matory cytokines must keep the lower respiratory track in a
state of downregulation in normal homeostasis. During the
course of inﬂammation, these transcription factors need to
be regulated to the “on” position for inﬂammatory cytokines
to be produced and released. Interestingly, the four major
inﬂammatory cytokines IL-1β,I L - 6 ,I L - 8 ,a n dT N F - α all
have NF-κB and C/EBPβ sites in their promoters [19].
During normal homeostasis, NF-κBi sb o u n dt oI κB and not
activated in the nucleus. C/EBPβ is expressed primarily in
the short 16kDa form which is inhibitory to transcription at
low levels of protein even at ratios of 1:5 with the 36kDa
activating form [20]. During AM activation, the inhibitory
form is de-repressed and the activating form predominates.
NF-κBi sr e l e a s e df r o mI κB and binds to its cognate DNA
binding site [21]. The combination of derepression and
activation provides a powerful signal for AM activation [22].
Oxidants are triggers for this process upon phagocytosis of
inorganic dust particles.
3. World Trade Center Dust
Nuisance dusts have not been regulated since they do not
cause a pneumoconiosis. The collapse of the World Trade
Center produced a huge cloud of nuisance dust containing
gypsum from wallboard, plastics, cement, ﬁbrous glass,
asbestos insulation, metals, and so forth. This acute, intense
dust exposure has resulted in a remarkable increase in
symptoms characterized by cough, wheeze, chest tightness,
gastroesophageal reﬂux, and so forth in ﬁreﬁghters, rescue
workers, and clean-up workers. Residents who returned
to their apartments and cleaned up the dust have also
been aﬀected [23]. Asthma has been found to have been
worsened, and there is an increase in newly diagnosed
asthma. Pulmonary function tests have found simultaneous
reductions in FVC and FEV1 that have been several-fold
greater than expected. Signiﬁcant declines in FEV1 were
noted shortly after the collapse. Pulmonary function tests
of peripheral airways function have been abnormal despite
normal spirometry [24]. Smoke from persistent ﬁres con-
taining polycyclic aromatic hydrocarbons, metals, and many
other chemicals exposed those involved in rescue and clean-
up operations.
Two weeks after the collapse we admitted a severely
dyspneic ﬁreﬁghter to Bellevue Hospital who was in acute
respiratory failure [25, 26]. His chest X-ray showed bilat-
eral pulmonary inﬁltrates and pleural eﬀusions. Following
treatmentwithsteroidsandantibioticsheimproved.Abron-
choalveolar lavage found 70% eosinophils in the diﬀerential,
and a diagnosis of acute eosinophilic pneumonia was made.
He had increased IL-5, an eosinophil chemoattractant, in
the BAL supernatants. Interestingly, his BAL eosinophils
showed intact granules containing major basic protein on
transmission electron microscopy. This suggested that the
eosinophilsalthoughrespondingtoastrongchemoattractant
signal had not become activated to release their granular
contents.Thiswasconsistentwiththepatient’sbenigncourse
and complete recovery from the pneumonia. However, the
ﬁreﬁghter continued to complain of World Trade Center
c o u g hf o rs e v e r a lm o r em o n t h s[ 27, 28].
4. Tropical PulmonaryEosinophilia(TPE)
Oxidants play a key role in tropical pulmonary eosinophilia
in causing both an acute disease and chronic interstitial
pulmonary ﬁbrosis. The eosinophil is central to this process,Mediators of Inﬂammation 3
and, in contrast to acute eosinophilic pneumonia, the
granules are empty and major basic protein has been
extruded [29]. This contributes to high oxidant stress in
the terminal respiratory bronchioles and alveoli. TPE is
an interstitial lung disease that results from a heightened
immunologic response to the human ﬁlarial parasites,
Wuchereria bancrofti and Brugia malayi. Individuals with
acute TPE characteristically present with cough, dyspnea,
nocturnal wheezing, and, occasionally, fever, anorexia, and
weight loss. It occurs in both males and females in the
younger age groups in India, Southeast Asia, and other
tropical regions. Filariasis is spread by mosquitoes, but only
a small portion of the population responds with the TPE
syndrome. There are a marked peripheral blood eosinophilia
(in contrast to acute eosinophilic pneumonia where our
ﬁreﬁghter had a normal blood eosinophil count) and high
serum concentrations of IgE and ﬁlarial speciﬁc antibodies.
Although most individuals with acute TPE have a rapid
clinical response to diethylcarbamazine or ivermectin, with
reduced cough and dyspnea, some individuals progress to a
chronic pulmonary ﬁbrosis. It is thought that the pulmonary
form of TPE results from degenerating microﬁlariae in the
pulmonary structures, but few have been found in lung
specimens, suggesting that most of the pathology seen and
symptoms arise from the lung inﬂammation and oxidants.
In a clinical study of TPE in India conducted by a joint
IndianCouncilofMedicalResearchandaNIHresearchteam
approvedbyHumanSubjectsReviewutilizingbronchoalveo-
lar lavage, eight individuals were bronchoscoped and a mean
of 54% eosinophils recovered in BAL [29]. Transmission EM
showed marked loss of granule content and disappearance of
dense central cores. Two of three individuals bronchoscoped
one year later still had marked BAL eosinophilia, although
reduced [29].
One year later, 23 subjects who had been treated were
reevaluated [30]. They had a mean age of 26 years, and
15 still complained of cough and nocturnal wheezing.
Only 3/20 had dyspnea, chest pain, or rales. They still
had tenfold increased IgE and IgG antiﬁlarial antibodies,
but much less than when ﬁrst studied [30]. Their BAL
had a mean of 6% eosinophils. There was a signiﬁcant
spontaneous increase in superoxide anion and hydrogen
peroxide release by the BAL cells over 30 minutes following
recovery in twenty chronic TPE subjects (6 smokers, 14
nonsmokers) compared to six normal nonsmokers a mean
of 8 months following diethylcarbamazine therapy [30]. In
order to reduce the inﬂammation in the lower respiratory
track, a short course of oral prednisone over one week was
attempted. The dose was 50mg followed by a daily 10mg
decline until they were oﬀ medication. Bronchoalveolar
lavage was performed prior to the beginning of the trial and
immediately thereafter. Twelve individuals completed the
trial, and the BAL percent eosinophils declined or remained
the same in all study subjects after a mean of seven days
of oral prednisone (Figure 1). Measurements of superoxide
anion and hydrogen peroxide were done on fresh BAL cells
recovered by bronchoscopy and superoxide anion declined
in 10/12 study subjects (Figure 2). In parallel, hydrogen
peroxide declined in 9/11 study subjects. Several clinical
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Figure 1: Suppression of lung eosinophils with prednisone in
TPE patients following after diethylcarbamazine therapy. 7±1d a y s
after prednisone therapy there was a reduction in the percent of
eosinophils observed in 12 subjects.
series from India, Southeast Asia, Africa, the West Indies,
and South America have described untreated TPE as a cause
of chronic interstitial lung disease [31]. In this regard, it
is recognized that if acute TPE is allowed to persist for
more than 6 months without treatment, restrictive lung
impairment is common. Open lung biopsies of individuals
with TPE untreated for >6 months reveal inﬁltration of the
alveolar structures and bronchiolar walls, with macrophages
and eosinophils together with granulomata laden with
eosinophils and multinucleated giant cells and interstitial
ﬁbrosis. The role of oxidants in causing interstitial lung
disease in chronic TPE is signiﬁcant, and this inﬂammatory
milieu can be modulated by anti-inﬂammatory treatment
with prednisone or ivermectin [32].
5. Summary
Air pollutants and oxidants can attract and activate inﬂam-
matory cells and signaling pathways which promote inﬂam-
mation. Inhibition of inﬂammatory pathways with corti-
costeroids such as c-Jun terminal kinase pathway in mice
attenuated O3-induced inﬂammation and hyperresponsive-
ness [33]. Oxidants increase NF-κB DNA binding along
with the release of IL-8 in lung epithelial cells, and this
eﬀect can be abrogated by antioxidant pretreatment [34].
Particulate-matter- (PM-) induced activation of NF-κBh a s
been shown to be dependent on the mitogen-activated
protein kinase signaling pathway, which is involved in the
stress response [35]. Nrf2 is another important transcription
factor that binds to antioxidant response elements leading
to the induction of various genes involved in mitigating4 Mediators of Inﬂammation
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Figure 2: Reduction in the spontaneous release of oxidants by lavage cells after prednisone therapy in TPE patients following diethylcarba-
mazine therapy. (a) Superoxide anion. (b) Hydrogen peroxide.
oxidantdamage[36].Particulatematterlessthan2.5microns
inairpollutionandinorganicparticlesactivateAMtorelease
superoxide anion and hydrogen peroxide and cause DNA
damage. Particles that cause DNA damage may also be
involved in lung carcinogenesis [37].
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